Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Orlistat and ezetimibe could differently alleviate the high-fat diet-induced obesity phenotype by modulating the gut microbiota
Jin Jin, Jiani Wang, Ruyue Cheng, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 21

Showing 21 citing articles:

The gut microbiota in obesity and weight management: microbes as friends or foe?
Matthias Van Hul, Patrice D. Cani
Nature Reviews Endocrinology (2023) Vol. 19, Iss. 5, pp. 258-271
Closed Access | Times Cited: 155
Gut microbiota and therapy for obesity and type 2 diabetes
Luyao Zhang, Pai Wang, Juan Huang, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 15
Targeting the Gut Microbiome to Treat Cardiometabolic Disease
Panagiotis Theofilis, Panayotis K. Vlachakis, Evangelos Oikonomou, et al.
Current Atherosclerosis Reports (2024) Vol. 26, Iss. 2, pp. 25-34
Closed Access | Times Cited: 9
Isoxanthohumol improves obesity and glucose metabolism via inhibiting intestinal lipid absorption with a bloom of Akkermansia muciniphila in mice
Yoshiyuki Watanabe, Shiho Fujisaka, Yoshitomo Morinaga, et al.
Molecular Metabolism (2023) Vol. 77, pp. 101797-101797
Open Access | Times Cited: 18
Semaglutide alleviates gut microbiota dysbiosis induced by a high-fat diet
Xinhao Duan, Lei Zhang, Yi Liao, et al.
European Journal of Pharmacology (2024) Vol. 969, pp. 176440-176440
Closed Access | Times Cited: 7
Peanut-natto improved obesity of high-fat diet mice by regulating gut microbiota and lipid metabolism
Shufang Cao, Lina Yang, Mengxi Xie, et al.
Journal of Functional Foods (2023) Vol. 112, pp. 105956-105956
Open Access | Times Cited: 14
Orlistat ameliorates lipid dysmetabolism in high-fat diet-induced mice via gut microbiota modulation
Chenxi Huang, Yuanhui He, Ping Chai, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access
Evaluation of gut microbiota alterations following orlistat administration in obese mice
Chang Xue, Tianying Wang, Yang Chen, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access
Intestinal flora: A new target for traditional Chinese medicine to improve lipid metabolism disorders
Min Liu, Wei Shi, Yefang Huang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10
Lactobacillus plantarumHF02 alleviates lipid accumulation and intestinal microbiota dysbiosis in high‐fat diet‐induced obese mice
Haoran Chen, Haiding Zhao, Xiaofen Qi, et al.
Journal of the Science of Food and Agriculture (2023) Vol. 103, Iss. 9, pp. 4625-4637
Closed Access | Times Cited: 10
Dietary diosgenin transcriptionally down-regulated intestinal NPC1L1 expression to prevent cholesterol gallstone formation in mice
Weiyi Shen, Wentao Shao, Qihan Wang, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 9
An Analysis of the Gut Microbiota and Related Metabolites following PCSK9 Inhibition in Statin-Treated Patients with Elevated Levels of Lipoprotein(a)
José A. Caparrós‐Martín, Patrice Maher, Natalie C. Ward, et al.
Microorganisms (2024) Vol. 12, Iss. 1, pp. 170-170
Open Access | Times Cited: 2
Association of lipid-lowering drugs with osteoarthritis outcomes from a drug-target Mendelian randomization study
Wei‐wei Ma, Honggu Chen, Zhiwen Zhang, et al.
PLoS ONE (2024) Vol. 19, Iss. 2, pp. e0293960-e0293960
Open Access | Times Cited: 2
Pharmacovigilance analysis of orlistat adverse events based on the FDA adverse event reporting system (FAERS) database
Jinfeng Zhu, Mianda Hu, Yingshi Liang, et al.
Heliyon (2024) Vol. 10, Iss. 14, pp. e34837-e34837
Open Access | Times Cited: 2
Association between lipid-lowering agents with intervertebral disc degeneration, sciatica and low back pain: a drug-targeted mendelian randomized study and cross-sectional observation
Chenxu Liu, Xinqiao Chu, Yaning Biao, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Pectin-derived oligogalacturonic acids ameliorate high-fat diet-induced obesity in mice by regulating gut microbiota and inflammation
Qian Li, Man Wang, Yue Zhang, et al.
Journal of Functional Foods (2023) Vol. 112, pp. 105928-105928
Open Access | Times Cited: 6
Complexation of starch and konjac glucomannan during screw extrusion exhibits obesity-reducing effects by modulating the intestinal microbiome and its metabolites
Fanrui Liu, Hao Wan, Heng Fan, et al.
Food & Function (2024)
Closed Access | Times Cited: 1
Association between lipid-lowering agents with intervertebral disc degeneration, sciatica and low back pain: A drug-targeted Mendelian randomized study and cross-sectional observation
Chenxu Liu, Xinqiao Chu, Yaning Biao, et al.
Research Square (Research Square) (2024)
Open Access
Influence of intestinal microbiota on the metabolism of main cardiotropic drugs
M. S. Stepanov
Perm Medical Journal (2024) Vol. 41, Iss. 5, pp. 54-65
Open Access
Increase in body weight is lowered when mice received fecal microbiota transfer from donor mice treated with the AT1 receptor antagonist telmisartan
M Freschi, Axel Künstner, Gianna Huber, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
CONSUMO DE PREBIÓTICOS, PROBIÓTICOS E TERAPIA FAMACOLÓGICA E SUA RELAÇÃO COM A MODULAÇÃO INTESTINAL NO TRATAMENTO DA OBESIDADE: UMA REVISÃO DA LITERATURA
Gabriela Cristina Uebel, Diene da Silva Schlickmann, M Eisenhardt, et al.
Revista Contemporânea (2023) Vol. 3, Iss. 12, pp. 26533-26553
Open Access
Page 1

Scroll to top